000 03970nam a22003735i 4500
999 _c80637
_d80637
_x1
001 80637
003 ES-MaUEC
005 20230207040313.0
007 cr nn 008mamaa
008 140317s2014 ja | s |||| 0|eng d
020 _a9784431544845
024 7 _a10.1007/978-4-431-54484-5
_2doi
040 _dES-MaUEC
050 4 _aRD129.5
_bM374 2014
245 1 0 _aMarginal Donors :
_bCurrent and Future Status
_cedited by Takehide Asano, Norihide Fukushima, Takashi Kenmochi, Naoto Matsuno.
260 _aTokyo
_bSpringer International Publishing
_c2014
300 _a1 recurso en línea (IX, 282 p.)
_b58 ilustraciones, 22 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _a1 History of Marginal Donors in the World -- 2 Management of Extended Criteria Donors -- 3 DCD for Heart Transplantation -- 4 ECD for Heart Transplantation -- 5 How to Initiate DCD Program for Lung Transplantation -- 6 DCD for Lung Transplantation -- 7 ECD for Lung Transplantation -- 8 LD for Lung Transplantation -- 9 How to Initiate DCD Program for Liver Transplantation -- 10 DCD for Liver Transplantation -- 11 ECD for Adult Liver Transplantation -- 12 LD for Liver Transplantation -- 13 How to Initiate a DCD Programme for Kidney Transplantation -- 14 DCD for Kidney Transplantation -- 15 Machine Perfusion Preservation for Kidney Transplantation -- 16 ECD for Kidney Transplantation -- 17 LD for Kidney Transplantation -- 18 DCD for Pancreas Transplantation -- 19 ECD for Pancreas Transplantation -- 20 LD for Pancreas Transplantation -- 21 DCD for Islet Transplantation -- 22 ECD for Islet Transplantation -- 23 ECD for Small Intestine Transplantation -- 24 ABO-Incompatible Donor.
520 _aIn response to persistent donor organ shortages, organs from marginal donors, such as expanded criteria donors (ECD) and donation after cardiac death (DCD) donors, are now accepted and have been successfully transplanted, reducing the waiting times for transplantation. Especially in Japan, transplantation of DCD kidneys has a relatively long history because of the difficulty or lack of national consensus in accepting brain death, which has made it possible to accumulate considerable clinical experience. Thus, the current organ shortage has stimulated interest in the use of marginal donors for transplantation. This book, prepared by distinguished authorities in their fields, is intended for clinicians and researchers. It highlights the use of marginal donors as a comparatively novel source of transplantation organs and provides a thorough overview of marginal donors from their historical origins to recent clinical applications, including the state-of-the-art science of organ/donor management, procurement, and preservation. Also provided is valuable information on ABO-incompatible donors which extend the availability of donor sources. Each chapter offers an individual analysis of the optimal requirements for the safe management and preservation of organs, including the heart, lung, liver, kidney, pancreas, and pancreatic islets.
650 7 _2embne
_9144138
_aDonación de órganos, tejidos, etc.
700 1 _aAsano, Takehide
_eeditor literario
_988996
_0Local
700 1 _aFukushima, Norihide
_eeditor literario
_988997
_0Local
700 1 _aKenmochi, Takashi
_eeditor literario
_988998
_0Local
700 1 _aMatsuno, Naoto
_eeditor literario
_988999
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-4-431-54484-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12883906
_b10-10-17
_c11-11-15
942 _2lcc
_cLE
945 _aRD129.5 M374 2014 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11563722
_z06-04-17
988 _aEBSPRINGER
998 _am
_a_alco
_a_vill
_b11-11-15
_cm
_dz
_e-
_feng
_gja
_h0